tiprankstipranks
Trending News
More News >
Labixiaoxin Snacks Group Ltd. (HK:1262)
:1262
Hong Kong Market

Labixiaoxin Snacks Group Ltd. (1262) AI Stock Analysis

Compare
0 Followers

Top Page

HK:1262

Labixiaoxin Snacks Group Ltd.

(1262)

Select Model
Select Model
Select Model
Neutral 46 (OpenAI - 5.2)
Rating:46Neutral
Price Target:
HK$2.50
▲(29.53% Upside)
The score is held down primarily by weak financial performance: losses, high leverage, and concerning/insufficient cash flow evidence. Technicals are a positive (uptrend and positive MACD), but the stock looks overextended (RSI/Stoch), and valuation is constrained by negative earnings and no stated dividend yield.
Positive Factors
Diversified distribution & channels
Diversified retail, wholesale and online distribution reduces single-channel concentration, stabilizing revenue across channels. Major retailer and e-commerce partnerships expand market reach, support scale economies and enable durable customer acquisition as consumption shifts to healthier packaged snacks.
Revenue growth momentum
A 13.39% top-line increase demonstrates sustained demand and product acceptance, creating a platform to leverage fixed costs. Continued revenue growth can enable scale-driven margin improvement, fund product and brand investment, and strengthen supplier negotiating power over the medium term.
Reasonable gross margin
A gross margin around 27% indicates product-level profitability potential and some cost control in manufacturing. That margin provides headroom for covering operating expenses as volumes rise; with disciplined cost management, it supports a credible path to improving operating margins over time.
Negative Factors
Negative operating profitability
A -10.79% net margin and negative operating/EBITDA margins show the company is loss-making at the operating level. Persistent operating losses erode equity and cash buffers, necessitate external funding or dilution, and constrain the firm’s ability to self-fund growth or resist shocks over the medium term.
High financial leverage
A debt-to-equity ratio of 2.13 signals elevated leverage that increases interest burden and refinancing risk. High leverage limits strategic flexibility, raises solvency concerns if cash flows remain weak, and makes the company more vulnerable to rate rises or demand slowdowns over the next several quarters.
Negative operating & free cash flow
The lack of positive operating and free cash flow in 2024 indicates the business is not generating internal liquidity to fund operations or investment. Continued cash deficits force reliance on external financing, restrict capex and working capital, and increase execution risk for long-term growth plans.

Labixiaoxin Snacks Group Ltd. (1262) vs. iShares MSCI Hong Kong ETF (EWH)

Labixiaoxin Snacks Group Ltd. Business Overview & Revenue Model

Company DescriptionLabixiaoxin Snacks Group Limited, an investment holding company, manufactures and sells jelly, confectionary, beverage, and other snack products in the People's Republic of China. It offers jelly snacks, such as fruit-flavored, canned fruit, yogurt, and mousse jellies; jelly beverages; lollipops, milk and gummy candies, and chocolates; fruit and vegetable beverages; and powdered milk tea, dried bean curd, and baked and beverage products under the Labixiaoxin, Sunshine City, Humor, and Xiangdoufang brands. The company was formerly known as China Lifestyle Food and Beverages Group Limited and changed its name to Labixiaoxin Snacks Group Limited in June 2012. The company was founded in 2000 and is headquartered in Jinjiang, the People's Republic of China. Labixiaoxin Snacks Group Limited is a subsidiary of Alliance Food and Beverages (Holding) Company Limited.
How the Company Makes MoneyLabixiaoxin Snacks Group Ltd. generates revenue through multiple key streams, primarily from the sale of its snack products to retailers, wholesalers, and directly to consumers. The company benefits from a diversified product portfolio, which allows it to target different market segments and adapt to changing consumer preferences. Significant revenue is derived from partnerships with major retailers and online platforms, enhancing its distribution reach. Additionally, Labixiaoxin invests in marketing and branding efforts to strengthen its market presence and foster customer loyalty, which further contributes to its earnings. The company also explores opportunities in international markets, expanding its customer base and enhancing revenue potential.

Labixiaoxin Snacks Group Ltd. Financial Statement Overview

Summary
Labixiaoxin Snacks Group Ltd. exhibits revenue growth but faces challenges in profitability and cash flow generation. High leverage and declining equity are key risks, while operational inefficiencies further pressure financial stability. Strategic improvements are necessary to enhance financial health.
Income Statement
45
Neutral
The company shows some revenue growth with a 13.39% increase from 2023 to 2024, but profitability is a concern given the negative net profit margin of -10.79% for 2024. The gross profit margin is 27.06%, indicating some cost control, but negative EBIT and EBITDA margins suggest operational inefficiencies.
Balance Sheet
40
Negative
The high debt-to-equity ratio of 2.13 in 2024 indicates significant leverage, posing financial stability risks. The equity ratio is 27.02%, showing moderate asset financing by equity, but a declining trend in stockholders' equity suggests weakened financial health.
Cash Flow
30
Negative
The absence of positive operating cash flow and free cash flow in 2024 is concerning, highlighting potential liquidity issues. Previous periods showed improvement in free cash flow, but the lack of data for 2024 prevents a comprehensive analysis.
BreakdownTTMDec 2024Dec 2023Dec 2022Dec 2021Dec 2020
Income Statement
Total Revenue888.87M866.67M764.38M684.26M648.07M508.84M
Gross Profit230.57M234.62M218.94M244.19M224.28M166.54M
EBITDA9.88M-35.72M-46.04M658.00K74.44M108.73M
Net Income-47.29M-93.46M-104.75M-75.33M-65.20M-29.40M
Balance Sheet
Total Assets837.13M793.84M810.91M977.31M1.29B1.53B
Cash, Cash Equivalents and Short-Term Investments47.48M52.50M44.32M71.88M80.57M258.84M
Total Debt461.94M456.40M451.27M512.44M565.59M690.74M
Total Liabilities620.09M579.32M588.35M650.00M887.41M1.06B
Stockholders Equity217.04M214.52M222.56M327.31M402.64M467.84M
Cash Flow
Free Cash Flow-16.58M-34.23M55.42M-4.98M-156.86M-21.57M
Operating Cash Flow37.98M31.53M88.64M15.46M-135.29M-12.47M
Investing Cash Flow-50.91M-65.54M-32.89M55.94M113.42M300.93M
Financing Cash Flow25.54M42.19M-83.31M-80.09M-156.41M-54.46M

Labixiaoxin Snacks Group Ltd. Technical Analysis

Technical Analysis Sentiment
Positive
Last Price1.93
Price Trends
50DMA
1.92
Positive
100DMA
1.92
Positive
200DMA
1.86
Positive
Market Momentum
MACD
0.21
Negative
RSI
83.10
Negative
STOCH
86.11
Negative
Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For HK:1262, the sentiment is Positive. The current price of 1.93 is below the 20-day moving average (MA) of 2.17, above the 50-day MA of 1.92, and above the 200-day MA of 1.86, indicating a bullish trend. The MACD of 0.21 indicates Negative momentum. The RSI at 83.10 is Negative, neither overbought nor oversold. The STOCH value of 86.11 is Negative, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Positive sentiment for HK:1262.

Labixiaoxin Snacks Group Ltd. Peers Comparison

Overall Rating
UnderperformOutperform
Sector (62)
Financial Indicators
Name
Overall Rating
Market Cap
P/E Ratio
ROE
Dividend Yield
Revenue Growth
EPS Growth
72
Outperform
HK$1.01B8.425.08%10.44%-1.19%-9.05%
71
Outperform
HK$300.00M11.365.48%0.78%5.43%-25.42%
68
Neutral
HK$2.32B10.4313.72%3.74%11.89%27.80%
64
Neutral
HK$439.90M9.194.62%13.51%2.82%-22.62%
63
Neutral
HK$981.63M93.530.79%0.00%-1.70%104.41%
62
Neutral
$20.33B14.63-3.31%3.23%1.93%-12.26%
46
Neutral
HK$585.36M-11.87-23.87%4.72%79.88%
* Consumer Defensive Sector Average
Performance Comparison
Ticker
Company Name
Price
Change
% Change
HK:1262
Labixiaoxin Snacks Group Ltd.
2.79
1.22
77.71%
HK:1583
Qinqin Foodstuffs Group (Cayman) Company
1.30
0.31
31.05%
HK:1285
Jiashili Group Ltd
1.06
0.08
8.16%
HK:1767
TS Wonders Holding Limited
0.30
0.12
66.67%
HK:1837
Natural Food International Holding Ltd.
1.05
0.59
128.26%
HK:2317
Vedan International (Holdings) Ltd.
0.66
0.22
50.00%

Labixiaoxin Snacks Group Ltd. Corporate Events

Labixiaoxin Snacks Group Enters Purchase Agreement with Jinjiang Longquan
Dec 1, 2025

Labixiaoxin Snacks Group Ltd. has entered into a Purchase Agreement with Jinjiang Longquan to buy products from 1 December 2025 to 31 December 2027. This agreement is classified as a continuing connected transaction under the Hong Kong Stock Exchange Listing Rules, requiring reporting and announcement but exempt from independent shareholders’ approval due to the applicable percentage ratios.

The most recent analyst rating on (HK:1262) stock is a Sell with a HK$1.50 price target. To see the full list of analyst forecasts on Labixiaoxin Snacks Group Ltd. stock, see the HK:1262 Stock Forecast page.

Glossary
BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.

Disclaimer

This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.Date of analysis: Jan 13, 2026